-
The loss of skeletal muscle mass in progressive supranuclear palsy
-
The main reasons for essential blepharospasm botulinum neurotoxin (BoNT) treatment discontinuation in Latvian population.
-
The mitochondrial targeted drug SBT-272 attenuates dopaminergic neuron loss, alpha-synuclein burden and neuroinflammation in a mouse model of Parkinson’s Disease
-
The MJFF Global Genetic Parkinson’s Disease Research Resource
-
The modification of iron accumulation in nigrosome by levodopa treatment in early Parkinson’s disease
-
The neural correlates of dynamic balance control in Parkinson’s disease and freezing of gait
-
The Neuropsychiatric Inventory:Assessment Of Neuropsychiatric Symptoms In Parkinson’s Disease
-
The OASIS (OpicApone in Sleep dISorder) study in Parkinson’s disease: design and rationale of an open-label, single-arm, pilot trial
-
The OCEAN (OpiCapone Effect on motor fluctuations and associated pAiN) study in Parkinson’s disease: design and rationale of a randomized double-blind placebo-controlled trial
-
The online MDS educational resources helped young neurologists maintain their training during the Covid-19 pandemic
- « Previous Page
- 1
- …
- 119
- 120
- 121
- 122
- 123
- …
- 132
- Next Page »